Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
12 03 2019
Historique:
received: 27 12 2017
accepted: 04 03 2019
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 12 2 2020
Statut: epublish

Résumé

Extended-spectrum cephalosporin resistance (ESC-R) in Escherichia coli and Klebsiella pneumoniae is a healthcare threat; high gastrointestinal carriage rates are reported from South-east Asia. Colonisation prevalence data in Cambodia are lacking. The aim of this study was to determine gastrointestinal colonisation prevalence of ESC-resistant E. coli (ESC-R-EC) and K. pneumoniae (ESC-R-KP) in Cambodian children/adolescents and associated socio-demographic risk factors; and to characterise relevant resistance genes, their genetic contexts, and the genetic relatedness of ESC-R strains using whole genome sequencing (WGS). Faeces and questionnaire data were obtained from individuals < 16 years in north-western Cambodia, 2012. WGS of cultured ESC-R-EC/KP was performed (Illumina). Maximum likelihood phylogenies were used to characterise relatedness of isolates; ESC-R-associated resistance genes and their genetic contexts were identified from de novo assemblies using BLASTn and automated/manual annotation. 82/148 (55%) of children/adolescents were ESC-R-EC/KP colonised; 12/148 (8%) were co-colonised with both species. Independent risk factors for colonisation were hospitalisation (OR: 3.12, 95% CI [1.52-6.38]) and intestinal parasites (OR: 3.11 [1.29-7.51]); school attendance conferred decreased risk (OR: 0.44 [0.21-0.92]. ESC-R strains were diverse; the commonest ESC-R mechanisms were bla Gastrointestinal ESC-R-EC/KP colonisation is widespread in Cambodian children/adolescents; hospital admission and intestinal parasites are independent risk factors. The genetic contexts of bla

Sections du résumé

BACKGROUND
Extended-spectrum cephalosporin resistance (ESC-R) in Escherichia coli and Klebsiella pneumoniae is a healthcare threat; high gastrointestinal carriage rates are reported from South-east Asia. Colonisation prevalence data in Cambodia are lacking. The aim of this study was to determine gastrointestinal colonisation prevalence of ESC-resistant E. coli (ESC-R-EC) and K. pneumoniae (ESC-R-KP) in Cambodian children/adolescents and associated socio-demographic risk factors; and to characterise relevant resistance genes, their genetic contexts, and the genetic relatedness of ESC-R strains using whole genome sequencing (WGS).
RESULTS
Faeces and questionnaire data were obtained from individuals < 16 years in north-western Cambodia, 2012. WGS of cultured ESC-R-EC/KP was performed (Illumina). Maximum likelihood phylogenies were used to characterise relatedness of isolates; ESC-R-associated resistance genes and their genetic contexts were identified from de novo assemblies using BLASTn and automated/manual annotation. 82/148 (55%) of children/adolescents were ESC-R-EC/KP colonised; 12/148 (8%) were co-colonised with both species. Independent risk factors for colonisation were hospitalisation (OR: 3.12, 95% CI [1.52-6.38]) and intestinal parasites (OR: 3.11 [1.29-7.51]); school attendance conferred decreased risk (OR: 0.44 [0.21-0.92]. ESC-R strains were diverse; the commonest ESC-R mechanisms were bla
CONCLUSIONS
Gastrointestinal ESC-R-EC/KP colonisation is widespread in Cambodian children/adolescents; hospital admission and intestinal parasites are independent risk factors. The genetic contexts of bla

Identifiants

pubmed: 30866820
doi: 10.1186/s12866-019-1431-9
pii: 10.1186/s12866-019-1431-9
pmc: PMC6417137
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cephalosporins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : #099423/Z/12/Z
Pays : United Kingdom

Références

Trans R Soc Trop Med Hyg. 2013 Apr;107(4):248-53
pubmed: 23418156
J Antimicrob Chemother. 2015;70(6):1893-7
pubmed: 25681128
Antimicrob Resist Infect Control. 2012 Nov 27;1(1):39
pubmed: 23181506
Antimicrob Agents Chemother. 2006 Apr;50(4):1257-62
pubmed: 16569837
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1223-9
pubmed: 25717021
J Clin Microbiol. 2005 Aug;43(8):4178-82
pubmed: 16081970
Int J Antimicrob Agents. 2010 Jul;36(1):73-8
pubmed: 20392607
J Antimicrob Chemother. 2012 Jan;67(1):240-2
pubmed: 21987239
mBio. 2015 Jun 09;6(3):e00762
pubmed: 26060276
Clin Microbiol Infect. 2006 Mar;12(3):279-84
pubmed: 16451416
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
mBio. 2016 May 05;7(3):
pubmed: 27150362
PLoS One. 2015 May 07;10(5):e0123719
pubmed: 25951607
Ann Intern Med. 1971 May;74(5):657-64
pubmed: 5559431
J Infect Dev Ctries. 2011 May 28;5(5):338-47
pubmed: 21628809
J Clin Microbiol. 2015 Jul;53(7):2122-31
pubmed: 25903575
J Antimicrob Chemother. 2013 Oct;68(10):2234-44
pubmed: 23722448
Antimicrob Agents Chemother. 2011 Nov;55(11):4971-8
pubmed: 21859935
Antimicrob Agents Chemother. 2014;58(3):1822-4
pubmed: 24395224
Trop Med Int Health. 2015 Jan;20(1):24-8
pubmed: 25324202
J Clin Microbiol. 2017 Jun;55(6):1638-1649
pubmed: 28298454
Trop Med Int Health. 2017 Feb;22(2):210-220
pubmed: 27935649
Lancet Infect Dis. 2008 Mar;8(3):159-66
pubmed: 18291338
Clin Infect Dis. 2009 Sep 1;49(5):682-90
pubmed: 19622043
Paediatr Int Child Health. 2016 May;36(2):113-7
pubmed: 25704569
Int J Infect Dis. 2018 Jan;66:74-79
pubmed: 29133211
mBio. 2016 Mar 22;7(2):e02162
pubmed: 27006459
FEMS Microbiol Rev. 2011 Sep;35(5):736-55
pubmed: 21303394
Pediatr Infect Dis J. 2016 Aug;35(8):856-61
pubmed: 27124686
Lancet Infect Dis. 2017 Jan;17(1):78-85
pubmed: 27751772
PLoS One. 2015 Sep 17;10(9):e0138179
pubmed: 26379031
J Antimicrob Chemother. 2012 Jul;67(7):1769-74
pubmed: 22514260
Curr Protoc Bioinformatics. 2010 Sep;Chapter 11:Unit 11.5
pubmed: 20836074
Mol Microbiol. 2006 Jun;60(5):1136-51
pubmed: 16689791
Emerg Infect Dis. 2009 May;15(5):741-8
pubmed: 19402960
PLoS Negl Trop Dis. 2014 May 22;8(5):e2880
pubmed: 24851867
Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):869-72
pubmed: 21271268
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
J Antimicrob Chemother. 2012 Jun;67(6):1311-20
pubmed: 22396430
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877

Auteurs

J J van Aartsen (JJ)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK. jjvanaartsen@outlook.com.
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK. jjvanaartsen@outlook.com.

C E Moore (CE)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

C M Parry (CM)

Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

P Turner (P)

Cambodia-Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

N Phot (N)

Angkor Hospital for Children, Siem Reap, Cambodia.

S Mao (S)

Angkor Hospital for Children, Siem Reap, Cambodia.

K Suy (K)

Angkor Hospital for Children, Siem Reap, Cambodia.

T Davies (T)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

A Giess (A)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

A E Sheppard (AE)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

T E A Peto (TEA)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

N P J Day (NPJ)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

D W Crook (DW)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

A S Walker (AS)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK.

N Stoesser (N)

Nuffield Department of Clinical Medicine and the National Institute for Health Research Oxford Biomedical Research Centre (NIHR-OxBRC), University of Oxford, Oxford, UK. nicole.stoesser@ndm.ox.ac.uk.
Department of Microbiology/Infectious Diseases, John Radcliffe Hospital, Headley Way, Headington, OX3 9DU, UK. nicole.stoesser@ndm.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH